United States Transdermal Drug Patches Market Research Report Forecast 2017-2021

June 2017 | 109 pages | ID: UC1393F9BA5EN
S&P Consulting

Abstracts

The United States Transdermal Drug Patches Market Research Report Forecast 2017-2021 is a valuable source of insightful data for business strategists. It provides the Transdermal Drug Patches industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Transdermal Drug Patches market study provides comprehensive data which enhances the understanding, scope and application of this report.

This report provides comprehensive analysis of

• Key market segments and sub-segments
• Evolving market trends and dynamics
• Changing supply and demand scenarios
• Quantifying market opportunities through market sizing and market forecasting
• Tracking current trends/opportunities/challenges
• Competitive insights
• Opportunity mapping in terms of technological breakthroughs

The Major players reported in the market include:

Boehringer Ingelheim
Janssen Pharmaceutica
GlaxoSmithKline
Mylan
Noven
Bayer
Actavis
Echo Therapeutics
Teva Pharmaceuticals

United States Transdermal Drug Patches Market: Product Segment Analysis

Single-layer Drug-in-Adhesive
Multi-layer Drug-in-Adhesive
Reservoir

United States Transdermal Drug Patches Market: Application Segment Analysis

• Application 1
• Application 2
• Application 3

Reasons for Buying this Report

• This report provides pin-point analysis for changing competitive dynamics
• It provides a forward looking perspective on different factors driving or restraining market growth
• It provides a six-year forecast assessed on the basis of how the market is predicted to grow
• It helps in understanding the key product segments and their future
• It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
• It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments

Contents

CHAPTER 1 TRANSDERMAL DRUG PATCHES MARKET OVERVIEW

1.1 Product Overview and Scope of Transdermal Drug Patches
1.2 Transdermal Drug Patches Market Segmentation by Type
  1.2.1 United States Production Market Share of Transdermal Drug Patches by Type in 2015
  1.2.1 Single-layer Drug-in-Adhesive
  1.2.2 Multi-layer Drug-in-Adhesive
  1.2.3 Reservoir
1.3 Transdermal Drug Patches Market Segmentation by Application
  1.3.1 Transdermal Drug Patches Consumption Market Share by Application in 2015
  1.3.2 Application
  1.3.3 Application
  1.3.4 Application
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Transdermal Drug Patches (2011-2021)

CHAPTER 2 UNITED STATES ECONOMIC IMPACT ON TRANSDERMAL DRUG PATCHES INDUSTRY

2.1 United States Macroeconomic Analysis
2.2 United States Macroeconomic Environment Development Trend

CHAPTER 3 UNITED STATES TRANSDERMAL DRUG PATCHES MARKET COMPETITION BY MANUFACTURERS

3.1 United States Transdermal Drug Patches Production and Share by Manufacturers (2015 and 2016)
3.2 United States Transdermal Drug Patches Revenue and Share by Manufacturers (2015 and 2016)
3.3 United States Transdermal Drug Patches Average Price by Manufacturers (2015 and 2016)
3.4 Manufacturers Transdermal Drug Patches Manufacturing Base Distribution, Production Area and Product Type
3.5 Transdermal Drug Patches Market Competitive Situation and Trends
  3.5.1 Transdermal Drug Patches Market Concentration Rate
  3.5.2 Transdermal Drug Patches Market Share of Top 3 and Top 5 Manufacturers
  3.5.3 Mergers & Acquisitions, Expansion

CHAPTER 4 UNITED STATES TRANSDERMAL DRUG PATCHES PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

4.1 United States Transdermal Drug Patches Production and Market Share by Type (2012-2017)
4.2 United States Transdermal Drug Patches Revenue and Market Share by Type (2012-2017)
4.3 United States Transdermal Drug Patches Price by Type (2012-2017)
4.4 United States Transdermal Drug Patches Production Growth by Type (2012-2017)

CHAPTER 5 UNITED STATES TRANSDERMAL DRUG PATCHES MARKET ANALYSIS BY APPLICATION

5.1 United States Transdermal Drug Patches Consumption and Market Share by Application (2012-2017)
5.2 United States Transdermal Drug Patches Consumption Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities
  5.3.1 Potential Applications
  5.3.2 Emerging Markets/Countries

CHAPTER 6 UNITED STATES TRANSDERMAL DRUG PATCHES MANUFACTURERS ANALYSIS

6.1 Boehringer Ingelheim
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Product Type, Application and Specification
  6.1.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Business Overview
6.2 Janssen Pharmaceutica
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Product Type, Application and Specification
  6.2.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Business Overview
6.3 GlaxoSmithKline
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Product Type, Application and Specification
  6.3.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Business Overview
6.4 Mylan
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Product Type, Application and Specification
  6.4.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Business Overview
6.5 Noven
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Product Type, Application and Specification
  6.5.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Business Overview
6.6 Bayer
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Product Type, Application and Specification
  6.6.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Business Overview
6.7 Actavis
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Product Type, Application and Specification
  6.7.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Business Overview
6.8 Echo Therapeutics
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Product Type, Application and Specification
  6.6.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Business Overview
6.9 Teva Pharmaceuticals
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Product Type, Application and Specification
  6.9.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Business Overview

CHAPTER 7 TRANSDERMAL DRUG PATCHES MANUFACTURING COST ANALYSIS

7.1 Transdermal Drug Patches Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Transdermal Drug Patches

CHAPTER 8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Transdermal Drug Patches Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Transdermal Drug Patches Major Manufacturers in 2015
8.4 Downstream Buyers

CHAPTER 9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

CHAPTER 10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

CHAPTER 11 UNITED STATES TRANSDERMAL DRUG PATCHES MARKET FORECAST (2017-2021)

11.1 United States Transdermal Drug Patches Production, Revenue Forecast (2017-2021)
11.2 United States Transdermal Drug Patches Production, Consumption Forecast by Regions (2017-2021)
11.3 United States Transdermal Drug Patches Production Forecast by Type (2017-2021)
11.4 United States Transdermal Drug Patches Consumption Forecast by Application (2017-2021)
11.5 Transdermal Drug Patches Price Forecast (2017-2021)

CHAPTER 12 APPENDIX

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Transdermal Drug Patches
Table Classification of Transdermal Drug Patches
Figure United States Sales Market Share of Transdermal Drug Patches by Type in 2015
Table Application of Transdermal Drug Patches
Figure United States Sales Market Share of Transdermal Drug Patches by Application in 2015
Figure United States Transdermal Drug Patches Sales and Growth Rate (2011-2021)
Figure United States Transdermal Drug Patches Revenue and Growth Rate (2011-2021)
Table United States Transdermal Drug Patches Sales of Key Manufacturers (2015 and 2016)
Table United States Transdermal Drug Patches Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Transdermal Drug Patches Sales Share by Manufacturers
Figure 2016 Transdermal Drug Patches Sales Share by Manufacturers
Table United States Transdermal Drug Patches Revenue by Manufacturers (2015 and 2016)
Table United States Transdermal Drug Patches Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Transdermal Drug Patches Revenue Share by Manufacturers
Table 2016 United States Transdermal Drug Patches Revenue Share by Manufacturers
Table United States Market Transdermal Drug Patches Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Transdermal Drug Patches Average Price of Key Manufacturers in 2015
Figure Transdermal Drug Patches Market Share of Top 3 Manufacturers
Figure Transdermal Drug Patches Market Share of Top 5 Manufacturers
Table United States Transdermal Drug Patches Sales by Type (2012-2017)
Table United States Transdermal Drug Patches Sales Share by Type (2012-2017)
Figure United States Transdermal Drug Patches Sales Market Share by Type in 2015
Table United States Transdermal Drug Patches Revenue and Market Share by Type (2012-2017)
Table United States Transdermal Drug Patches Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Transdermal Drug Patches by Type (2012-2017)
Table United States Transdermal Drug Patches Price by Type (2012-2017)
Figure United States Transdermal Drug Patches Sales Growth Rate by Type (2012-2017)
Table United States Transdermal Drug Patches Sales by Application (2012-2017)
Table United States Transdermal Drug Patches Sales Market Share by Application (2012-2017)
Figure United States Transdermal Drug Patches Sales Market Share by Application in 2015
Table United States Transdermal Drug Patches Sales Growth Rate by Application (2012-2017)
Figure United States Transdermal Drug Patches Sales Growth Rate by Application (2012-2017)
Table Boehringer Ingelheim Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Boehringer Ingelheim Transdermal Drug Patches Production, Revenue, Price and Gross Margin (2012-2017)
Table Boehringer Ingelheim Transdermal Drug Patches Market Share (2012-2017)
Table Janssen Pharmaceutica Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Janssen Pharmaceutica Transdermal Drug Patches Production, Revenue, Price and Gross Margin (2012-2017)
Table Janssen Pharmaceutica Transdermal Drug Patches Market Share (2012-2017)
Table GlaxoSmithKline Basic Information, Manufacturing Base, Production Area and Its Competitors
Table GlaxoSmithKline Transdermal Drug Patches Production, Revenue, Price and Gross Margin (2012-2017)
Table GlaxoSmithKline Transdermal Drug Patches Market Share (2012-2017)
Table Mylan Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Mylan Transdermal Drug Patches Production, Revenue, Price and Gross Margin (2012-2017)
Table Mylan Transdermal Drug Patches Market Share (2012-2017)
Table Noven Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Noven Transdermal Drug Patches Production, Revenue, Price and Gross Margin (2012-2017)
Table Noven Transdermal Drug Patches Market Share (2012-2017)
Table Bayer Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Bayer Transdermal Drug Patches Production, Revenue, Price and Gross Margin (2012-2017)
Table Bayer Transdermal Drug Patches Market Share (2012-2017)
Table Actavis Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Actavis Transdermal Drug Patches Production, Revenue, Price and Gross Margin (2012-2017)
Table Actavis Transdermal Drug Patches Market Share (2012-2017)
Table Echo Therapeutics Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Echo Therapeutics Transdermal Drug Patches Production, Revenue, Price and Gross Margin (2012-2017)
Table Echo Therapeutics Transdermal Drug Patches Market Share (2012-2017)
Table Teva Pharmaceuticals Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Teva Pharmaceuticals Transdermal Drug Patches Production, Revenue, Price and Gross Margin (2012-2017)
Table Teva Pharmaceuticals Transdermal Drug Patches Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Transdermal Drug Patches
Figure Manufacturing Process Analysis of Transdermal Drug Patches
Figure Transdermal Drug Patches Industrial Chain Analysis
Table Raw Materials Sources of Transdermal Drug Patches Major Manufacturers in 2015
Table Major Buyers of Transdermal Drug Patches
Table Distributors/Traders List
Figure United States Transdermal Drug Patches Production and Growth Rate Forecast (2017-2021)
Figure United States Transdermal Drug Patches Revenue and Growth Rate Forecast (2017-2021)
Table United States Transdermal Drug Patches Production Forecast by Type (2017-2021)
Table United States Transdermal Drug Patches Consumption Forecast by Application (2017-2021)